The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| NHLBI Program Project Applications (P01 Clinical Trials Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-24-065 |
| Adolescent Overdose Prevention and SUD Treatment Initiative (R34 - Clinical Trial Optional) |
93.279 |
RFA-DA-25-031 |
| Adolescent Overdose Prevention and SUD Treatment Initiative (R21 - Clinical Trial Not Allowed) |
93.273, 93.279 |
RFA-DA-25-030 |
| Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) |
93.866 |
PAR-24-052 |
| Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R25 Independent Clinical Trial Not Allowed) |
93.361 |
PAR-24-061 |
| Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) |
93.859 |
PAR-24-032 |
| Initiative for Maximizing Student Development (IMSD) (T32) |
93.859 |
PAR-24-031 |
| In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional) |
93.173 |
RFA-DC-24-004 |
| Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required) |
93.173 |
RFA-DC-24-005 |
| NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
93.398 |
PAR-23-287 |
| NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) |
93.398 |
PAR-23-288 |
| NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) |
93.398 |
PAR-23-286 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required) |
93.279 |
RFA-DA-25-027 |
| National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-029 |
| Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional) |
93.273, 93.279 |
PAR-24-062 |
| Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed) |
93.307, 93.310 |
RFA-OD-24-006 |
| Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only) |
93.279 |
RFA-DA-24-036 |
| Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional) |
93.350 |
PAR-24-054 |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
93.846 |
PAR-24-036 |
| Advancing Genomic Medicine Research (R21 Clinical Trial Optional) |
93.172, 93.393 |
RFA-HG-23-033 |
| Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required) |
93.121, 93.213, 93.233, 93.273, 93.279, 93.307, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840 |
PAR-24-053 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) |
93.846 |
PAR-24-035 |
| Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-23-048 |
| Advancing Genomic Medicine Research (R01 Clinical Trial Optional) |
93.172, 93.393 |
RFA-HG-23-032 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-24-049 |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
93.855 |
PAR-23-282 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-24-043 |
| Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-23-043 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-24-063 |
| Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed) |
93.865 |
RFA-HD-25-008 |
| BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-24-028 |
| HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.233, 93.273, 93.279, 93.313, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-24-019 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
93.394 |
PAR-23-313 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
93.394 |
PAR-23-314 |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) |
93.242 |
RFA-MH-24-180 |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) |
93.242 |
RFA-MH-24-181 |
| Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional) |
93.279 |
RFA-DA-25-058 |
| IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-24-001 |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
93.393 |
PAR-24-039 |
| Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and other Cargoes for HIV and SUD Mechanistic or Therapeutic Research (R01 Clinical Trial Optional) |
93.279 |
RFA-DA-25-022 |
Search Results 281-320 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
